Semaglutide Cost at a Medspa: What You Actually Pay and Why

semaglutide cost medspa

One of the most common questions I hear from patients researching medical weight loss is: “Why does semaglutide cost so much more at a medspa than what I see online?” The answer is layered — and understanding it helps you both make a smarter decision as a patient and, if you are a medspa operator, price your program correctly without losing business to telehealth competitors you cannot realistically compete with on price alone.

This guide walks through what semaglutide actually costs at a medspa, what drives those price differences, what the cost at different provider types looks like, what a well-structured program should include at each price point, and what questions to ask before you sign up. I will also cover the compliance considerations for how medspas can market these programs — because cost transparency is one of the single highest-converting elements of a GLP-1 landing page.

1. The Actual Cost Range: What Medspas Charge for Semaglutide Programs

Semaglutide pricing at medspas is not standardized — it varies based on whether the practice uses branded or compounded medication, whether monitoring and consultations are bundled or billed separately, and local market conditions. Based on what I observe across markets, here is a realistic range:

• Compounded semaglutide only (medication, no program): est. $150–$350 per month depending on dose
• Compounded semaglutide plus monthly check-in visit: est. $250–$450 per month
• Full program (medication, lab monitoring, nutrition coaching, body comp tracking): est. $350–$600 per month
• Initiation/consultation fee (often billed separately): est. $99–$299 one-time
• Lab work if billed separately: est. $75–$200 per panel depending on what is ordered

These ranges reflect the medspa channel specifically. Telehealth-only providers (Hims, Ro, Found, Calibrate, and dozens of smaller operators) typically charge est. $150–$299 per month for compounded semaglutide with async provider oversight. The price difference between telehealth and medspa reflects in-person clinical services, hands-on monitoring, and aesthetic integration — not medication markup alone.

2. Branded vs. Compounded Semaglutide: The Biggest Cost Driver

The single largest factor in semaglutide cost at any provider type is whether the medication is branded or compounded. Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management) are the branded versions manufactured by Novo Nordisk. At a retail pharmacy without insurance, Ozempic runs est. $900–$1,000 per month and Wegovy runs est. $1,300–$1,600 per month. With insurance that covers it, patient out-of-pocket can drop to near zero — but coverage for weight management indication remains inconsistent.

Compounded semaglutide is produced by 503A or 503B licensed compounding pharmacies and is typically priced at est. $150–$400 per month depending on dose, pharmacy, and whether it is sold through a provider at a markup. Compounding is legal when an FDA-approved medication is on the shortage list — semaglutide has been on the shortage list, which enabled the compounding market to explode. The FDA has indicated it intends to end compounding authorization as supply normalizes, so the regulatory status of compounded semaglutide is an active and evolving situation.

From a marketing standpoint, medspas using compounded semaglutide need to be careful not to imply the product is equivalent to the branded version — it has not gone through the same FDA approval process, though many patients and providers consider it functionally equivalent at lower cost.

3. What a Medspa Semaglutide Program Should Include at Every Price Tier

Before you enroll in any program, get clarity on exactly what is included at the price you are quoted. Here is what I consider reasonable inclusions at each tier:

At est. $200–$300 per month: compounded semaglutide at appropriate starting dose, a telehealth or in-person initial consultation, a basic intake questionnaire covering contraindications, and at minimum one monthly check-in (even asynchronous).

At est. $300–$450 per month: everything above plus monthly in-person provider visit, dose titration guidance with clinical rationale explained, basic body composition tracking (weight and measurements at minimum, InBody or bioelectrical impedance at better practices), and access to a clinical team by phone or messaging for questions between visits.

At est. $450–$600+ per month: everything above plus baseline and quarterly lab work included in program cost, a nutrition protocol or coaching sessions, integration with aesthetic services (body contouring, IV therapy, skin tightening consultations), and a plateau protocol with documented clinical response rather than just medication adjustment.

If a practice is charging $400+ per month and cannot tell you clearly what monitoring they do, what labs they order, and what happens when you stop losing weight at month three, that is a significant red flag regardless of how elegant the branding is.

4. Why Medspa Semaglutide Costs More Than Telehealth (And When the Premium Is Worth It)

The telehealth semaglutide providers have optimized aggressively for low cost and high volume. An async telehealth provider may have one prescriber overseeing hundreds or thousands of patients simultaneously, which is legally permissible in most states for non-scheduled medications but means your individual clinical oversight is minimal.

The medspa premium buys you: an in-person prescriber relationship with a provider who can physically assess how your body is responding, immediate adjustment capability if you experience significant side effects (nausea, fatigue, gastrointestinal distress are common early in treatment), access to body composition monitoring that distinguishes fat loss from muscle loss (an important distinction for overall health), and integration with aesthetic treatments that address the physical changes accompanying significant weight reduction.

Whether that premium is worth it depends on your individual clinical situation. If you are generally healthy, have no complex medication interactions to manage, and are comfortable with async clinical care, telehealth may be appropriate. If you have comorbidities, have had significant medication sensitivities in the past, or value in-person clinical relationship and accountability, the medspa program structure is worth the additional cost for most patients.

5. How to Compare Medspa Semaglutide Programs Without Getting Misled by Price

Price comparison between programs is almost meaningless without understanding what is inside each price. A $250/month program that includes medication only is not comparable to a $450/month program that includes medication, labs, monthly visits, and nutrition coaching. You are not comparing the same product.

The questions that actually matter when comparing programs: Is baseline and ongoing lab work included or billed separately? How many provider visits are included per month, and are they in-person or telehealth? What is the clinical protocol when weight loss plateaus? What happens if you experience significant side effects — can you reach a provider within 24 hours? Is there a long-term contract or cancellation penalty? What happens to the program if the FDA changes compounding authorization?

Asking these questions in a consultation tells you far more about program quality than the monthly price alone. The medspa marketing resource library has templates for how practices can present this information clearly to patients, which also happens to improve conversion by building trust early in the patient journey.

6. Insurance and HSA/FSA Coverage for Medspa Semaglutide

Insurance coverage for semaglutide at medspas is the exception, not the rule. Most commercial insurance plans that cover semaglutide do so only through in-network pharmacies for specific FDA-approved indications (Ozempic for type 2 diabetes management, Wegovy for BMI-qualifying chronic weight management). Compounded semaglutide through a medspa program is almost universally not covered by insurance.

HSA and FSA dollars are generally eligible for prescription medications and medical consultations, which means a patient with a high-deductible health plan and a funded HSA can often use those pre-tax dollars toward a medspa GLP-1 program. This is a meaningful marketing point for practices targeting higher-income patients — paying est. $400/month with pre-tax HSA dollars is effectively 20–30% less expensive than paying post-tax, depending on the patient’s marginal rate.

Always instruct patients to confirm HSA/FSA eligibility with their plan administrator before assuming coverage, and make sure your practice can provide the itemized receipts required for HSA reimbursement documentation.

7. How Medspas Should Price Their GLP-1 Programs for Profitability

For medspa operators reading this: pricing a GLP-1 program requires honest accounting of your actual costs, not just medication cost plus a margin. Factor in: prescriber time per patient per month (whether salaried, contracted, or per-visit), medication cost at your compounding pharmacy at target doses across a typical patient cohort, lab costs if included, administrative overhead for intake and monitoring, and the patient acquisition cost amortized over estimated program duration.

A common mistake is pricing based on medication cost alone and discovering that the program is operationally unprofitable once full staff time is counted. Medspas that run sustainable GLP-1 programs typically price at est. 2.5–3.5x medication cost when medication is the primary variable expense, or use a base program fee structure that covers clinical services with medication passed through at a modest markup.

The medspa revenue calculator can help you model what a GLP-1 program contributes to total practice revenue at different enrollment and retention assumptions, which is useful for setting growth targets before you invest in marketing spend.

8. Communicating Cost on Your Website Without Losing Leads

The debate about whether to publish pricing on a medspa GLP-1 landing page is, in my experience, settled by conversion data: transparent pricing almost always outperforms price-hidden landing pages for this specific patient segment. GLP-1 patients are highly researched buyers who distrust providers who will not give them a cost estimate upfront. They have comparison-shopped telehealth options that publish pricing clearly. A “call for pricing” CTA reads as evasion to a patient who has already seen exact prices from your competitors.

Publishing pricing does not prevent you from selling higher tiers in the consultation — it gets the patient in the door. Lead generation is a prerequisite for upselling. If you are concerned about price shoppers who will not convert, consider publishing “programs starting at est. $X/month” with a clear explanation that a consultation determines which program fits the patient’s clinical profile.

9. The Real Cost Comparison When You Factor In Results

One framing I find useful for patients who are sticker-shocked at medspa pricing: compare the monthly cost to what they have spent on alternatives. A patient who has done three rounds of Noom, two HMR programs, and a gym membership renewal over the past two years has typically spent more than a year of medspa GLP-1 program costs — with less consistent results.

This is not a manipulative sales tactic — it is an honest reframing. The question is not “is $400/month a lot?” The question is “what is the cost of continuing to not solve this problem?” For patients who have been struggling with weight management for years, an evidence-based, medically supervised program at $400/month often represents the best value they have found, even if it is not the cheapest option in absolute terms.

10. What to Expect at Different Points in the Cost-Results Curve

Understanding what you are paying for at each stage of a GLP-1 program helps set realistic expectations. Month one is typically the titration phase — dose starts low (est. 0.25mg semaglutide weekly) to minimize gastrointestinal side effects. Weight loss in month one is often modest: est. 2–5 pounds for most patients. Month two through three is where the dose reaches a therapeutic level and weight loss accelerates — est. 1–2 pounds per week for patients responding well. Months four through six often involve a plateau, dose optimization, and consolidation of earlier losses.

A program that is not providing clinical guidance through the plateau phase is not worth a premium price regardless of what it costs. The plateau is where most patients quit telehealth-only programs — and where a well-run medspa program creates the most value by keeping the patient engaged, adjusting the protocol, and preventing the regain that undermines months of progress. Book a free consultation if you want to discuss what a structured program looks like for your specific situation.